This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A broad discussion looking at the competitive landscape of the Life Science antibody and reagent market

Ticker(s): TMO, MRK, A, BIO

Who's the expert?

Institution: Private Practice, Life Science Consulting

  • Independent consultant with 25+ years of experience in the life science reagent market
  • Previous Sales and Product Director at Innova Biosciences and Abcam

Interview Questions
Q1.

Describe your background and research setting

Added By: ben_admin
Q2.

Who are the current leaders in the antibody/reagent markets?

Added By: ben_admin
Q3.

What technological advancements have been made in this space?

Added By: ben_admin
Q4.

Do you see a lot of mergers and acquisitions in this space driving companies right now or are a lot of companies just developing their own stuff?

Added By: slingshot_insights
Q5.

Are major players in this conjugate market, also major players in the labeled primary and labeled secondary? Or do you find that some or most companies are more specialized?

Added By: slingshot_insights
Q6.

Is the quality of antibodies a big focus on being competitive on price?

Added By: slingshot_insights
Q7.

If you're able to do hundreds or thousands of samples now, in terms of sample preparation, are researchers able to keep up with that?

Added By: slingshot_insights
Q8.

Are there any companies that you think are real disruptors that you're keeping an eye on?

Added By: slingshot_insights

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.